| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/11/2004 | US20040048848 Novel gamma secretase inhibitors |
| 03/11/2004 | US20040048843 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion |
| 03/11/2004 | DE10238865A1 New carboxamides are melanin-concentrating hormone receptor antagonists, useful for treating e.g. metabolic diseases, diabetes, eating disorders, cardiovascular disease, emotional disorders, reproductive and memory disorders |
| 03/11/2004 | CA2496812A1 Novel processes and intermediates for preparing triazolo-pyridines |
| 03/11/2004 | CA2495248A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases |
| 03/11/2004 | CA2494754A1 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds |
| 03/10/2004 | EP1396493A1 Heterocyclic compounds |
| 03/10/2004 | EP1396490A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives |
| 03/10/2004 | EP1396488A1 Fused heterocyclic compound and medicinal use thereof |
| 03/10/2004 | EP1395606A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 03/10/2004 | EP1395591A1 Corticotropin releasing factor antagonists |
| 03/10/2004 | EP1395590A2 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]indole derivatives as prostaglandin d2 receptor antagonists |
| 03/10/2004 | EP1395586A2 Method for the production of zolpidem |
| 03/10/2004 | EP1395585A1 Antibacterial agents |
| 03/10/2004 | EP1395584A1 Uronium and immonium salts for peptide coupling |
| 03/10/2004 | EP1395583A1 New phenylpiperazines |
| 03/10/2004 | EP1395288A1 A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases |
| 03/10/2004 | EP1395261A2 Pyridylpyrimidine derivatives as effective compounds against prion diseases |
| 03/10/2004 | EP1236725B1 Novel 1,8-naphthyridin-2(1h)-one derivatives |
| 03/10/2004 | EP1177196B1 Heteroaryl diazabicycloalkanes, their preparation and use |
| 03/10/2004 | EP1157025B1 Pyrazolopyridines |
| 03/10/2004 | EP0994875B1 3-pyridyl-1-azabicycloalkane derivatives for prevention and treatment of cns disorders |
| 03/10/2004 | CN1481435A Ligand and complex for catlytically bleaching substrate |
| 03/10/2004 | CN1481376A Oxybenzamides derivatives as factor xa inhibitors |
| 03/10/2004 | CN1481368A Gyrase imhibitors and uses thereof |
| 03/10/2004 | CN1481365A Cyclization process step in making of quinolones and naphthyridines |
| 03/10/2004 | CN1141295C Indoline derivatives as progesterohe antagonists |
| 03/09/2004 | US6703512 Intermediates for the production of quinolone carboxylic acid derivatives |
| 03/09/2004 | US6703505 Process for the preparation of high purity Pemirolast |
| 03/09/2004 | US6703404 Nitric oxide synthase inhibitors |
| 03/09/2004 | US6703401 Compounds, their preparation and use |
| 03/09/2004 | US6703391 Quinoxalinedione derivatives, their preparation and use |
| 03/09/2004 | US6703385 Tricyclic compounds having sPLA2-inhibitory activities |
| 03/04/2004 | WO2004018466A2 A method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives |
| 03/04/2004 | WO2004018465A2 Benzonaphthyridines with pde 3/4 inhibiting activity |
| 03/04/2004 | WO2004018428A1 Antibacterial benzoic acid derivatives |
| 03/04/2004 | WO2004018419A2 Benzimidazole quinolinones and uses thereof |
| 03/04/2004 | WO2004018414A2 Antibacterial agents |
| 03/04/2004 | WO2004018058A2 Compounds, compositions, and methods |
| 03/04/2004 | WO2004017995A1 Preventive and/or therapeutic drugs for itch |
| 03/04/2004 | WO2004017922A2 Keto cannabinoids with therapeutic indications |
| 03/04/2004 | WO2004005287A9 Pyrazoloisoquinoline derivatives for inhibiting nfkappab-inducing kinase (nik) |
| 03/04/2004 | WO2003082350A3 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 03/04/2004 | WO2003072042A3 Malonate-claisen rearrangement for preparation of integrin receptor antagonist intermediates |
| 03/04/2004 | WO2002094197A3 Bicyclic inhibitors of factor xa |
| 03/04/2004 | US20040044207 Aza-and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors |
| 03/04/2004 | US20040044205 Continuous countercurrent chromatography; bactericides, food adjuvants |
| 03/04/2004 | US20040044198 Reacting chlorin with base; heating, acidification; used for photodynamic therapy |
| 03/04/2004 | US20040044197 Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy |
| 03/04/2004 | US20040044062 Method of treatment of viral infection including HIV using water soluble fullerenes - III |
| 03/04/2004 | US20040044052 N-Aryl-2-oxazolidinone-5-carboxamides and their derivatives |
| 03/04/2004 | US20040044044 Thiazolyl urea compounds and methods of uses |
| 03/04/2004 | US20040044037 Sleep disorders; antidepressants; analgesics; central nervous system disorders |
| 03/04/2004 | US20040044029 Azabicyclic compounds are central nervous system active agents |
| 03/04/2004 | US20040044027 Induce immunology response; central nervous system disorders;sleep disorders; gastrointestinal disorders |
| 03/04/2004 | US20040044025 Polymerase inhibitors; aid therapy |
| 03/04/2004 | US20040044024 Dihydrodipyrazolopyridinone inhibitors of B7-1 |
| 03/04/2004 | US20040044021 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 03/04/2004 | US20040044018 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 03/04/2004 | US20040044014 Controlling signal transduction; tyrosine kinase inhibitors; benign prostatic hyperplasmia; respiratory system disorders; antitumor agents |
| 03/04/2004 | US20040044012 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 03/04/2004 | US20040043994 Antitumor agents, endometriosis, vision defects, antiarthritic agents, angiogenesis inhibitors |
| 03/04/2004 | US20040043989 Therapy for drug resistant bacteria; topoisomerase inhibitor |
| 03/04/2004 | US20040043988 Cycloalkyl alkanoic acids as intergrin receptor antagonists |
| 03/04/2004 | US20040043986 Cardiovascular disorders; inflammatory bowel disorders; antiarthritic agents; skin disorders; vision defects; osteoporosis |
| 03/04/2004 | US20040043984 3,4-Dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
| 03/04/2004 | US20040043977 Alzheimer's disease |
| 03/04/2004 | CA2496464A1 Agent for prevention and/or treatment of itching |
| 03/04/2004 | CA2496097A1 Keto cannabinoids with therapeutic indications |
| 03/04/2004 | CA2495603A1 Benzonaphthyridines with pde 3/4 inhibiting activity |
| 03/04/2004 | CA2493244A1 A method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives |
| 03/03/2004 | EP1394238A1 Cyclic nitroxyl compounds as additives for lubricating oils |
| 03/03/2004 | EP1394152A1 2-iminoimidazole derivatives (1) |
| 03/03/2004 | EP1393747A1 Preventives/remedies for alzheimer's disease |
| 03/03/2004 | EP1393719A1 Camptothecin-carboxylate formulations |
| 03/03/2004 | EP1392689A1 Tri- and tetraaza-acenaphthylen derivatives as crf receptor antagonists |
| 03/03/2004 | EP1392688A1 Pyrazino[1',2':1,6]pyrido[3,4-b]indole1,4-dione derivatives |
| 03/03/2004 | EP1392687A1 1,3,8-triazaspiro[4,5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders |
| 03/03/2004 | EP1392686A1 Bicyclic nitrogen-containing heterocyclic derivatives for use as antibacterials |
| 03/03/2004 | EP1392677A2 Chiral broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions |
| 03/03/2004 | EP1392658A1 Novel fused indazoles and indoles and their use for the treatment of glaucoma |
| 03/03/2004 | EP1392641A1 Substituted cyclohexane-1,4-diamine derivatives |
| 03/03/2004 | EP1392310A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors |
| 03/03/2004 | EP1392307A1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 03/03/2004 | EP1392298A2 Fused heterocyclic compounds |
| 03/03/2004 | EP1392283A1 Substituted coumarins and quinolines as caspases activators |
| 03/03/2004 | EP1392280A2 Arylsulfonamide ethers, and methods of use thereof |
| 03/03/2004 | EP1392264A1 Delivery of antiemetics through an inhalation route |
| 03/03/2004 | EP1392262A1 Delivery of drug esters through an inhalation route |
| 03/03/2004 | EP1392261A2 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 03/03/2004 | EP1392259A2 Delivery of erectile dysfunction drugs through an inhalation route |
| 03/03/2004 | EP1392257A1 Delivery of antihistamines through an inhalation route |
| 03/03/2004 | EP0986386B1 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases |
| 03/03/2004 | CN1479740A Substituted 3,4-dihydro-pyrido [1,2-a] pyrimidines |
| 03/03/2004 | CN1479739A Heterocyclic ether substituted imidazoquinolie compounds |
| 03/03/2004 | CN1479738A Thioether subsituted imidazoquinoline compound |
| 03/03/2004 | CN1479724A Pyridione derivatives for tretment of atherosclerosis |
| 03/03/2004 | CN1478779A Tosylate and benzene sulfonate of pyrazolopy ridone compound |
| 03/03/2004 | CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor |
| 03/03/2004 | CN1140511C Amino piperidine derivatives as integrin alphabeta 3 antagonists |